A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
Clinical trial NCT03231800 · COMPLETED
Trial details
- NCT number
- NCT03231800
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-31
- Primary completion
- 2019-03-15
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.